Clinical Trials Sponsored by R&R Inc.

Total 1525 results

Galderma R&D

Completed

A Post Market Evaluation After Treatment of Nasolabial Folds

Nasolabial Folds

China
Galderma R&D

Completed

Perception of Facial Expressions Following Correction of Wrinkles and Folds

Wrinkles and Folds in Lower Face

Germany
Galderma R&D

Completed

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Scalp Psoriasis

United States
Galderma R&D

Completed

Swedish Macrolane Registry

Breast Augmentation

Sweden
Galderma R&D

Completed

Safety and Efficacy Study of Lip Injections With Emervel Lips Lidocaine and Juvéderm Volbella With Lidocaine

Lip Filler Injections

Sweden, Germany
Galderma R&D

Completed

Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee

Knee Osteoarthritis

United Kingdom
Galderma R&D

Completed

A Non-interventional Study to Evaluate the Use of Pliaglis in Daily Practice

Health Knowledge, Attitudes, Practice

France, Germany, Spain, United Kingdom
Galderma R&D

Completed

A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine

Safety

Sweden
Galderma R&D

Completed

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris

Acne

United States
Galderma R&D

Terminated

Treatment w/ Tri-Luma® Cream & Intense Pulsed Light (IPL) vs a Mild Inactive Control Cream & Intense Pulsed Light (IPL) in Melasma

Melasma

United States
Galderma R&D

Completed

Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes

P Acnes Colonization

United States
Galderma R&D

Completed

Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin

Skin Manifestations

United States
Galderma R&D

Completed

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

Skin Manifestations

United States
Galderma R&D

Completed

Cetaphil® Daily Facial Moisturizer With Sunscreen SPF 50+ - Human Repeat Insult Patch Test

Skin Irritation

United States
Galderma R&D

Completed

Evaluate Safety/Efficacy of Two Treatment Regimens for Vectical™ Ointment & Clobex® Spray for Moderate Plaque Psoriasis

Plaque Psoriasis

United States, Canada
Galderma R&D

Completed

Assessment of Atrophogenic Potential of Triple Combination Cream for Treatment of Melasma

Melasma

United States
Galderma R&D

Completed

A Comparison Between Clobetasol Propionate 0.05% (Clobex®) Spray and Clobetasol Propionate 0.05% (Olux®) Foam

Psoriasis

United States
Galderma R&D

Completed

Assess the Ability of MetroGel 1% to Deliver Moisture to Facial Skin After a Single Application

Rosacea

United States
Galderma R&D

Completed

Repeat Insult Patch Test of Skin Irritation/Sensitization for Cetaphil Daily Facial Cleanser

Skin Irritation

United States
Galderma R&D

Completed

Patch Test Skin Irritation/Sensitization of Cetaphil Restoraderm Skin Restoring Body Wash

Skin Irritation

United States
Galderma R&D

Completed

Efficacy and Safety of Therapy With Tri-Luma® Cream in Sequence With Glycolic Acid Peels for Melasma

Melasma

United States
Galderma R&D

Completed

Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%

Acne

United States
Galderma R&D

Completed

Efficacy and Safety Study of CD2027 Ointment 3 Microgram Per Gram (mcg/g) Twice Daily Treatment for Adults With at Least Moderate Atopic Dermatitis

Atopic Dermatitis

United States
C. R. Bard

Terminated

The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation (WAVE-Global)

Chronic Kidney Diseases | End Stage Kidney Disease | Kidney Disease, Chronic | Kidney Failure | AV Fistula | Kidney Insufficiency | Fistulas Arteriovenous

Switzerland, Belgium, Greece
C. R. Bard

Completed

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft (AVeNEW)

Restenosis | Stenosis

Australia, Germany, Austria, United States, Belgium, New Zealand, Netherlands, Switzerland
Galderma R&D

Completed

Participant Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Active, not recruiting

Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency

Midface Volume Deficit

China
Galderma R&D

Completed

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL) (CTCL)

Cutaneous T Cell Lymphoma

United States, France, Germany
Galderma R&D

Completed

Oracea Soolantra Association in Participants With Severe Rosacea (ANSWER)

Rosacea

United States, Canada, Hungary
Galderma R&D

Completed

Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea

Erythematotelangiectatic Rosacea

United States
Galderma R&D

Completed

Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Patient Education in Adherence on Acne (PEAce)

Acne

United Kingdom
Galderma R&D

Completed

Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses (CoMet)

Actinic Keratoses

Australia
Galderma R&D

Completed

Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses (COMET2)

Actinic Keratoses

Spain, France, Germany, Netherlands, Sweden
Galderma R&D

Completed

PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK (SESAME 2)

Actinic Keratoses

Germany
Galderma R&D

Completed

A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States, Germany, Canada, Hungary, Poland
Galderma R&D

Completed

Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis

Psoriasis Vulgaris

United States, Canada, Belgium, Germany, Italy
Galderma R&D

Completed

Clobetasol Propionate 0.05% Shampoo in Association With Antifungal Shampoo in Scalp Seborrheic Dermatitis (Escape)

Scalp Seborrheic Dermatitis

Belgium, France, Germany, Korea, Republic of, Mexico
Galderma R&D

Completed

Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne (EDeN)

Acne Vulgaris

United States, Mauritius, Singapore
Galderma R&D

Completed

Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne

Acne

United States
Galderma R&D

Completed

Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea

Rosacea

United States
Galderma R&D

Completed

A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis

Chronic Plaque Psoriasis

United States, Canada
Galderma R&D

Completed

Single-blind Evaluation of Device to Nail Micro-drilling in Onychomycosis

Onychomycosis

United States
Galderma R&D

Completed

Comparison of Metvix Photodynamic Therapy (PDT) With Its Vehicle in the Treatment of Photoaged Skin

Photoaged Skin

United Kingdom
Galderma R&D

Completed

Comparison of Two Tri-Luma® Maintenance Regimens in the Treatment of Melasma (CLARA)

Melasma

Brazil, Mexico
C. R. Bard

Completed

A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair (ATLAS)

Hernia, Ventral | Incisional Hernia

United States
C. R. Bard

Completed

Study Comparing Lutonix AV Drug Coated Balloon vs Standard Balloon for Treatment of Dysfunctional AV Fistulae

Arteriovenous Fistula

United States
C. R. Bard

Completed

Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft in AV Graft Patients (AVeVA) (AVeVA)

Restenosis | Stenosis

United States
Galderma R&D

Completed

Safety and Efficacy of Nemolizumab in PN

Prurigo Nodularis

Germany, Poland, France, Austria

3

Subscribe